ANGLE plc (LON:AGL – Get Free Report)’s stock price passed above its 50 day moving average during trading on Wednesday . The stock has a 50 day moving average of GBX 9.88 ($0.12) and traded as high as GBX 12 ($0.15). ANGLE shares last traded at GBX 12 ($0.15), with a volume of 479,401 shares.
Wall Street Analysts Forecast Growth
Separately, Berenberg Bank restated a “buy” rating and set a GBX 70 ($0.87) target price on shares of ANGLE in a research report on Thursday, September 26th.
View Our Latest Research Report on AGL
ANGLE Price Performance
ANGLE Company Profile
ANGLE plc, a medical diagnostic company, engages in developing cancer diagnostics products in Europe, North America, and the United Kingdom. The company develops and commercializes Parsortix cell separation system, which captures and harvests circulating tumor cells in metastatic breast cancer patient blood; and HyCEAD.
See Also
- Five stocks we like better than ANGLE
- Procter & Gamble (NYSE:PG) Pulls Back After Shaky Guidance
- Moderna Shares Spike on H5N1 News—What’s Next for Investors?
- Russell 2000 Index, How Investors Use it For Profitable Trading
- Nebius Group (NBIS): A Small-Cap Backed by NVIDIA
- Best Stocks Under $5.00
- Natural Gas Demand to Surge: Top 3 Stocks and ETFs to Consider
Receive News & Ratings for ANGLE Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ANGLE and related companies with MarketBeat.com's FREE daily email newsletter.